[Parkinson's syndrome and L-dopa]

Arq Neuropsiquiatr. 1971 Jun;29(2):174-83. doi: 10.1590/s0004-282x1971000200005.
[Article in Portuguese]
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Clinical Trials as Topic
  • Dihydroxyphenylalanine / adverse effects
  • Dihydroxyphenylalanine / therapeutic use*
  • Evaluation Studies as Topic
  • Female
  • Humans
  • Male
  • Middle Aged
  • Parkinson Disease / drug therapy*
  • Placebos

Substances

  • Placebos
  • Dihydroxyphenylalanine